Jointown Pharmaceutical Group Co., Ltd. Class A

Jointown Pharmaceutical Group Co., Ltd. Class A

SSSE:600998
5.27
CNY
+0.02
(+0.38%)
0.41EPS
13.11P/E
25.46BMarket Cap
Apr 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.84
9.8
11.41
14.09
16.54
17.63
18.2
21.44
23.6
26.63
29.7
30.27
31.49
33.69
Basic EPS, GAAP
0.13
0.13
0.16
0.2
0.32
0.27
0.32
0.59
0.47
0.4
0.43
0.5
0.44
0.39
Free Cash Flow per Basic Share
-0.13
-0.27
-0.13
-0.16
-0.47
-0.12
0.29
0.38
0.4
0.52
0.73
0.42
0.4
- -
Dividend per Share
0.1
0.13
0.11
0.17
0.16
0.2
0.21
0.14
0.32
0.26
0.32
0.31
0.29
0.28
Book Value per Share
1.33
1.7
2.11
2.49
3.57
3.62
3.66
3.93
4.25
4.49
4.76
5.05
5.31
5.45
Tangible Book Value per Share
1.15
1.52
1.89
2.24
3.31
3.34
3.15
3.37
3.68
3.93
4.2
4.46
4.51
4.68
Basic Weighted Avg Shares
3,783
4,191
4,346
4,369
4,471
4,942
5,466
5,172
5,188
5,274
5,056
5,015
5,125
5,091
Sales/Revenue/Turnover
33,438
41,068
49,589
61,557
73,943
87,136
99,497
110,860
122,407
140,424
150,140
151,810
161,390
171,509
Operating Margin (%)
2.49
2.49
2.77
2.91
3
3.1
3.51
3.68
2.84
2.85
3.02
2.78
2.51
2.54
Depreciation Expense
149
162
221
277
351
403
497
514
657
736
775
857
836
- -
Net Income, GAAP
478
561
695
877
1,446
1,341
1,727
3,075
2,448
2,085
2,174
2,507
2,255
1,962
Effective Tax Rate (%)
22.4
24.57
26.36
18.21
23.47
24.54
23.13
21.9
22.44
19.47
23.44
23.4
26.76
27.54
Profit Margin (%)
1.43
1.37
1.4
1.42
1.95
1.54
1.74
2.77
2
1.48
1.45
1.65
1.4
1.14
Working Capital
3,574
5,236
6,212
6,904
12,771
12,531
12,955
14,740
15,775
15,973
15,559
17,822
18,942
20,607
LT Debt
1,610
1,596
1,600
1,289
1,462
1,626
2,724
3,374
2,559
3,176
2,507
1,717
2,496
2,609
Total Equity
5,339
7,814
9,846
12,010
19,538
20,460
21,968
25,610
27,073
28,685
29,477
33,593
36,868
38,632
Return on Invested Capital (%)
3.59
3.65
3.98
4.72
6.31
4.55
5.13
8.48
6.36
5.24
5.28
6.14
4.93
- -
Return on Capital (%)
7.02
6.54
6.86
7.74
8.39
6.53
7.62
8.91
7.25
6.52
6.96
7.06
5.76
- -
Return on Common Equity (%)
9.87
8.88
8.23
8.6
9.94
7.37
9.38
16.04
11.87
9.46
9.32
10.14
8.63
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
16,096
16,091
14,848
LT Borrowings
2,252
2,205
1,895
LT Finance Leases
812
775
715
Preferred Equity and Hybrid Capital
1,772
1,772
1,772
Shares Outstanding
5,042
5,042
5,042
Market Capitalization
26,624
23,649
25,464

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
100,730
99,623
103,136
Cash, Cash Equivalents & STI
19,901
22,500
22,928
Accounts Receivable, Net
37,449
35,672
37,994
Inventories
29,931
29,096
29,377
Total Current Liabilities
80,421
79,874
82,529
Payables & Accruals
- -
- -
- -
ST Debt
16,096
16,091
14,848
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.15%
7.63%
9.75%
Free Cash Flow
-16.85%
5.05%
-3.25%
Net Income, GAAP
16.5%
-5.14%
-10.07%
Sales/Revenue/Turnover
12.72%
7.9%
6.31%
Total Cash Common Dividend
19.29%
23.71%
-4.77%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
40,472
36,699
36,258
38,381
151,810
2025
42,016
39,090
- -
42,063
161,390
2026
44,783
42,497
42,166
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.13
0.1
0.16
0.5
2025
0.19
0.1
- -
0.06
0.44
2026
0.14
0.09
0.1
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.22
0.02
0.02
0.31
2025
0.02
0.22
- -
0.01
0.29
2026
0.02
0.22
0.04
- -
- -

Company Description

CEO
Yi Hua Gong
Full Time Employees
29,862
Sector
Distribution services
Industry
Medical distributors
Address
No. 5, Longxing West Street Wuhan HB China 430051
IPO Date
Oct 25, 2010
Website
jztey.com
Business
Jointown Pharmaceutical Group Co., Ltd specializes in the distribution and wholesale of pharmaceuticals and medical products across China. Its core businesses include digital pharmaceutical distribution and supply chain services; general agency brand promotion; pharmaceutical industrial self-production and OEM manufacturing; new retail and a 10,000-store alliance plan targeting consumer-end markets; medical health and technology value-added services; and digital logistics and intelligent supply chain solutions. The company manufactures western medicines such as antibiotics, antidiabetic drugs, cardiovascular drugs, topical medications, and respiratory infection drugs, along with Chinese herbal and patent medicines. It also produces medical consumables including gloves, surgical masks, and medical equipment. Jointown operates the largest network of medical warehouses in China and one of the largest globally, spanning over 44 million square feet, serving all 31 provinces in mainland China with a vast subsidiary network and services to hospitals, pharmacies, and e-commerce platforms. Founded in 1999, the company is headquartered in Wuhan, Hubei Province, China. Recent major developments include Jointown's strategic investment to participate in the restructuring of Aoyuan Meigu, enhancing its Medical Beauty business segment and expanding its presence in the medical aesthetics market through synergy and supply chain integration. Jointown also signed a strategic cooperation agreement with BGM Group to promote licorice extract and compound licorice tablets, deepening its partnerships in pharmaceutical product promotion. Additionally, Jointown completed the issuance of 1 billion yuan in asset-backed bonds to support its operations and growth strategies. The company continues advancing its digital and intelligent logistics capabilities to strengthen its supply chain ecosystem across pharmaceutical and medical industries, reinforcing its position as a technology-driven comprehensive service provider for the whole pharmaceutical industry chain. Overall, Jointown integrates manufacturing, distribution, retail, and technology-driven supply chain solutions to serve healthcare institutions, pharmacies, medical beauty institutions, and consumers across China, maintaining a diversified portfolio that includes self-produced medicines, OEM products, medical devices, and health-related consumables.